Takeda’s Alofisel becomes Europe’s first allogenic stem cell therapy – PMLiVE
PMLiVE |
Takeda's Alofisel becomes Europe's first allogenic stem cell therapy
PMLiVE Takeda has chalked up a big win this week after receiving a European licence for Alofisel (darvadstrocel), marking the first approved allogenic stem cell therapy set to hit the EU market. Alofisel – previously Cx601 – is approved to treat complex … |
